
AstraZeneca PLC (AZN.L) Financial Statements
Price: $11438
Market Cap: $177.36B
Avg Volume: 2.74M
Market Cap: $177.36B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of AstraZeneca PLC.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $54.07B | $45.81B | $44.35B | $37.42B | $26.62B | $24.38B | $22.09B | $22.46B | $23.00B | $24.71B |
Cost of Revenue | $10.21B | $8.04B | $12.39B | $12.44B | $5.30B | $4.92B | $4.94B | $4.32B | $4.13B | $4.65B |
Gross Profit | $43.87B | $37.77B | $31.96B | $24.98B | $21.32B | $19.46B | $17.15B | $18.15B | $18.88B | $20.06B |
Gross Profit Ratio | 81.12% | 82.40% | 72.06% | 66.80% | 80.09% | 79.82% | 77.66% | 80.78% | 82.06% | 81.20% |
Research and Development Expenses | $13.58B | $10.94B | $9.76B | $9.74B | $5.99B | $5.96B | $5.93B | $5.76B | $5.89B | $6.00B |
General and Administrative Expenses | $19.98B | $19.22B | $- | $- | $- | $11.68B | $- | $10.23B | $9.41B | $11.11B |
Selling and Marketing Expenses | $555.00M | $539.00M | $18.95B | $15.68B | $11.69B | $11.85B | $10.36B | $10.54B | $9.74B | $11.45B |
Selling General and Administrative Expenses | $20.53B | $18.02B | $18.95B | $15.68B | $11.69B | $11.85B | $10.36B | $10.54B | $9.74B | $11.45B |
Other Expenses | $-252.00M | $618.00M | $-514.00M | $-1.49B | $-1.53B | $-1.54B | $-650.00M | $-10.44B | $-9.74B | $-11.63B |
Operating Expenses | $33.86B | $29.58B | $28.20B | $23.92B | $16.16B | $16.27B | $13.77B | $14.47B | $13.97B | $15.95B |
Cost and Expenses | $44.07B | $37.62B | $40.59B | $36.36B | $21.45B | $21.19B | $18.70B | $18.79B | $18.10B | $20.59B |
Interest Income | $458.00M | $301.00M | $95.00M | $43.00M | $87.00M | $172.00M | $138.00M | $113.00M | $67.00M | $46.00M |
Interest Expense | $1.74B | $1.59B | $1.35B | $1.30B | $1.31B | $1.43B | $1.42B | $1.51B | $1.38B | $1.07B |
Depreciation and Amortization | $6.69B | $4.93B | $5.25B | $4.10B | $2.90B | $3.76B | $3.75B | $3.04B | $2.36B | $2.85B |
EBITDA | $17.12B | $13.91B | $9.09B | $5.11B | $8.08B | $6.71B | $7.11B | $6.62B | $7.28B | $6.96B |
EBITDA Ratio | 31.66% | 30.37% | 21.03% | 20.22% | 31.45% | 28.77% | 32.44% | 30.14% | 31.71% | 28.31% |
Operating Income | $10.00B | $8.19B | $3.76B | $1.06B | $5.16B | $2.92B | $3.39B | $3.68B | $4.90B | $4.11B |
Operating Income Ratio | 18.50% | 17.88% | 8.47% | 2.82% | 19.39% | 11.99% | 15.33% | 16.37% | 21.31% | 16.65% |
Total Other Income Expenses Net | $-1.31B | $-1.29B | $-1.26B | $-1.32B | $-1.25B | $-1.38B | $-1.39B | $-1.45B | $-1.35B | $-1.04B |
Income Before Tax | $8.69B | $6.90B | $2.50B | $-265.00M | $3.92B | $1.55B | $1.99B | $2.23B | $3.55B | $3.07B |
Income Before Tax Ratio | 16.07% | 15.06% | 5.64% | -0.71% | 14.71% | 6.35% | 9.02% | 9.91% | 15.44% | 12.42% |
Income Tax Expense | $1.65B | $938.00M | $-792.00M | $-380.00M | $772.00M | $321.00M | $-57.00M | $-641.00M | $146.00M | $243.00M |
Net Income | $7.04B | $5.96B | $3.29B | $112.00M | $3.20B | $1.33B | $2.15B | $3.00B | $3.50B | $2.83B |
Net Income Ratio | 13.01% | 13.00% | 7.41% | 0.30% | 12.01% | 5.47% | 9.76% | 13.36% | 15.21% | 11.43% |
EPS | $4.53 | $3.81 | $2.12 | $0.08 | $2.44 | $1.03 | $1.70 | $2.37 | $2.77 | $2.23 |
EPS Diluted | $4.51 | $3.81 | $2.11 | $0.08 | $2.44 | $1.03 | $1.70 | $2.37 | $2.76 | $2.23 |
Weighted Average Shares Outstanding | 1.55B | 1.56B | 1.55B | 1.42B | 1.31B | 1.30B | 1.27B | 1.27B | 1.26B | 1.26B |
Weighted Average Shares Outstanding Diluted | 1.56B | 1.56B | 1.56B | 1.43B | 1.31B | 1.30B | 1.27B | 1.27B | 1.27B | 1.26B |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $5.49B | $5.84B | $6.17B | $6.33B | $7.83B | $5.37B | $4.83B | $3.32B | $5.02B | $6.24B |
Short Term Investments | $166.00M | $20.00M | $239.00M | $69.00M | $160.00M | $849.00M | $849.00M | $1.23B | $884.00M | $613.00M |
Cash and Short Term Investments | $5.65B | $5.86B | $6.41B | $6.40B | $7.99B | $6.22B | $5.68B | $4.55B | $5.90B | $6.85B |
Net Receivables | $- | $8.41B | $7.21B | $6.03B | $3.81B | $3.58B | $3.00B | $2.80B | $2.58B | $4.63B |
Inventory | $5.29B | $5.42B | $4.70B | $8.98B | $4.02B | $3.19B | $2.89B | $3.04B | $2.33B | $2.14B |
Other Current Assets | $14.88B | $5.36B | $4.44B | $4.83B | $3.68B | $2.57B | $4.03B | $2.76B | $2.42B | $2.38B |
Total Current Assets | $25.83B | $25.05B | $22.59B | $26.24B | $19.54B | $15.56B | $15.59B | $13.15B | $13.26B | $16.01B |
Property Plant Equipment Net | $11.65B | $10.50B | $9.45B | $10.17B | $8.92B | $8.34B | $7.42B | $7.62B | $6.85B | $6.41B |
Goodwill | $21.02B | $20.05B | $19.82B | $20.00B | $11.85B | $11.67B | $11.71B | $11.82B | $11.66B | $11.87B |
Intangible Assets | $37.18B | $38.09B | $39.31B | $42.39B | $20.95B | $20.83B | $21.96B | $26.19B | $27.59B | $22.65B |
Goodwill and Intangible Assets | $58.20B | $58.14B | $59.13B | $62.38B | $32.79B | $32.50B | $33.67B | $38.01B | $39.24B | $34.51B |
Long Term Investments | $1.73B | $1.78B | $903.00M | $1.17B | $987.00M | $610.00M | $113.00M | $-194.00M | $-58.00M | $-70.00M |
Tax Assets | $5.35B | $- | $3.26B | $4.33B | $3.44B | $2.72B | $2.38B | $2.19B | $1.10B | $1.29B |
Other Non-Current Assets | $1.28B | $5.65B | $1.15B | $1.07B | $1.05B | $1.65B | $1.48B | $2.58B | $2.13B | $1.97B |
Total Non-Current Assets | $78.21B | $76.06B | $73.89B | $79.12B | $47.19B | $45.81B | $45.06B | $50.20B | $49.26B | $44.12B |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $104.03B | $101.12B | $96.48B | $105.36B | $66.73B | $61.38B | $60.65B | $63.35B | $62.53B | $60.12B |
Account Payables | $22.46B | $3.27B | $2.55B | $2.82B | $2.35B | $1.77B | $1.72B | $2.29B | $1.68B | $3.47B |
Short Term Debt | $2.50B | $5.40B | $6.50B | $2.89B | $2.42B | $2.05B | $1.78B | $2.27B | $2.33B | $925.00M |
Tax Payables | $1.41B | $2.08B | $896.00M | $916.00M | $1.13B | $1.36B | $1.16B | $1.35B | $1.38B | $1.48B |
Deferred Revenue | $- | $- | $- | $- | $- | $- | $1.37B | $-6.44B | $-5.88B | $-6.50B |
Other Current Liabilities | $1.50B | $19.80B | $16.34B | $15.96B | $14.41B | $12.94B | $11.63B | $10.48B | $9.87B | $8.99B |
Total Current Liabilities | $27.87B | $30.54B | $26.29B | $22.59B | $20.31B | $18.12B | $16.29B | $16.38B | $15.26B | $14.87B |
Long Term Debt | $27.62B | $23.22B | $24.63B | $30.47B | $20.29B | $18.38B | $19.20B | $17.39B | $16.52B | $14.14B |
Deferred Revenue Non-Current | $- | $7.00M | $14.00M | $26.00M | $38.00M | $50.00M | $78.00M | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $3.31B | $31.00M | $2.94B | $6.21B | $2.92B | $2.49B | $3.29B | $4.00B | $3.96B | $2.73B |
Other Non-Current Liabilities | $4.37B | $8.15B | $8.50B | $13.01B | $10.49B | $10.28B | $11.11B | $12.94B | $14.08B | $12.61B |
Total Non-Current Liabilities | $35.30B | $31.41B | $33.13B | $43.48B | $30.78B | $28.66B | $30.32B | $30.33B | $30.60B | $26.75B |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $63.16B | $61.95B | $59.42B | $66.08B | $51.09B | $46.78B | $46.61B | $46.71B | $45.86B | $41.62B |
Preferred Stock | $- | $949.00M | $1.62B | $- | $- | $143.00M | $- | $- | $- | $- |
Common Stock | $388.00M | $388.00M | $387.00M | $387.00M | $328.00M | $328.00M | $317.00M | $317.00M | $316.00M | $316.00M |
Retained Earnings | $3.16B | $4.52B | $-574.00M | $1.71B | $5.30B | $2.81B | $5.68B | $8.22B | $8.14B | $11.83B |
Accumulated Other Comprehensive Income Loss | $- | $- | $-1.62B | $111.00M | $881.00M | $-143.00M | $34.00M | $1.01B | $99.00M | $1.66B |
Other Total Stockholders Equity | $37.24B | $33.29B | $33.53B | $35.13B | $7.97B | $7.80B | $4.43B | $4.39B | $4.35B | $4.30B |
Total Stockholders Equity | $40.79B | $39.14B | $37.04B | $39.27B | $15.62B | $13.13B | $12.47B | $14.96B | $14.85B | $18.49B |
Total Equity | $40.87B | $39.17B | $37.06B | $39.29B | $15.64B | $14.60B | $14.04B | $16.64B | $16.67B | $18.51B |
Total Liabilities and Stockholders Equity | $104.03B | $101.12B | $96.48B | $105.36B | $66.73B | $61.38B | $60.65B | $63.35B | $62.53B | $60.12B |
Minority Interest | $85.00M | $23.00M | $21.00M | $19.00M | $16.00M | $1.47B | $1.58B | $1.68B | $1.81B | $19.00M |
Total Liabilities and Total Equity | $104.03B | $101.12B | $96.48B | $105.36B | $66.73B | $61.38B | $60.65B | $63.35B | $62.53B | $60.12B |
Total Investments | $1.90B | $1.68B | $1.14B | $1.24B | $1.15B | $1.46B | $922.00M | $1.04B | $826.00M | $543.00M |
Total Debt | $30.11B | $28.62B | $29.23B | $30.78B | $20.38B | $18.23B | $19.11B | $17.81B | $16.81B | $15.05B |
Net Debt | $24.63B | $22.78B | $23.07B | $24.45B | $12.55B | $12.86B | $14.28B | $14.48B | $11.79B | $8.81B |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $8.69B | $6.90B | $2.50B | $-265.00M | $3.92B | $1.55B | $1.99B | $2.23B | $3.55B | $3.07B |
Depreciation and Amortization | $6.69B | $4.93B | $5.48B | $6.53B | $3.15B | $3.76B | $3.75B | $3.04B | $2.36B | $2.85B |
Deferred Income Tax | $- | $- | $-619.00M | $-615.00M | $-277.00M | $-259.00M | $- | $- | $- | $- |
Stock Based Compensation | $- | $579.00M | $619.00M | $615.00M | $277.00M | $259.00M | $219.00M | $220.00M | $241.00M | $211.00M |
Change in Working Capital | $-893.00M | $300.00M | $3.76B | $2.02B | $361.00M | $-346.00M | $-639.00M | $-50.00M | $926.00M | $-49.00M |
Accounts Receivables | $- | $-1.43B | $-1.35B | $-961.00M | $-739.00M | $-898.00M | $-523.00M | $83.00M | $1.61B | $152.00M |
Inventory | $- | $-669.00M | $3.94B | $1.58B | $-621.00M | $-316.00M | $-13.00M | $-548.00M | $-343.00M | $-315.00M |
Accounts Payables | $- | $1.43B | $1.35B | $961.00M | $739.00M | $898.00M | $- | $- | $- | $- |
Other Working Capital | $-893.00M | $969.00M | $-184.00M | $444.00M | $982.00M | $-30.00M | $-626.00M | $498.00M | $1.27B | $266.00M |
Other Non Cash Items | $-2.62B | $-2.37B | $-1.93B | $-2.32B | $-2.63B | $-2.00B | $-2.49B | $-1.64B | $-2.69B | $-2.55B |
Net Cash Provided by Operating Activities | $11.86B | $10.35B | $9.81B | $5.96B | $4.80B | $2.97B | $2.62B | $3.58B | $4.14B | $3.32B |
Investments in Property Plant and Equipment | $-1.92B | $-1.36B | $-2.57B | $-2.20B | $-2.61B | $-2.46B | $-1.37B | $-1.62B | $-2.31B | $-2.79B |
Acquisitions Net | $-3.93B | $-1.18B | $-1.06B | $-9.43B | $-830.00M | $-783.00M | $-536.00M | $-1.96B | $-2.90B | $-3.07B |
Purchases of Investments | $-96.00M | $-136.00M | $-159.00M | $-184.00M | $-119.00M | $-13.00M | $-102.00M | $-441.00M | $-396.00M | $-57.00M |
Sales Maturities of Investments | $108.00M | $129.00M | $42.00M | $105.00M | $2.13B | $212.00M | $429.00M | $70.00M | $3.00M | $376.00M |
Other Investing Activities | $-2.14B | $-1.52B | $789.00M | $654.00M | $1.14B | $2.39B | $2.54B | $1.62B | $1.64B | $1.30B |
Net Cash Used for Investing Activities | $-7.98B | $-4.06B | $-2.96B | $-11.06B | $-285.00M | $-657.00M | $963.00M | $-2.33B | $-3.97B | $-4.24B |
Debt Repayment | $1.81B | $-965.00M | $-1.51B | $7.89B | $1.65B | $-1.19B | $1.47B | $224.00M | $2.48B | $4.41B |
Common Stock Issued | $-43.00M | $33.00M | $29.00M | $29.00M | $30.00M | $3.52B | $34.00M | $43.00M | $47.00M | $43.00M |
Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $-4.63B | $-4.48B | $-4.36B | $-3.86B | $-3.57B | $-3.59B | $-3.48B | $-3.52B | $-3.56B | $-3.49B |
Other Financing Activities | $-1.13B | $-1.15B | $-973.00M | $-418.00M | $-308.00M | $3.01B | $-33.00M | $316.00M | $-285.00M | $-93.00M |
Net Cash Used Provided by Financing Activities | $-4.00B | $-6.57B | $-6.82B | $3.65B | $-2.20B | $-1.76B | $-2.04B | $-2.94B | $-1.32B | $878.00M |
Effect of Forex Changes on Cash | $-93.00M | $-60.00M | $-80.00M | $-62.00M | $12.00M | $5.00M | $-38.00M | $-66.00M | $21.00M | $-76.00M |
Net Change in Cash | $-208.00M | $-346.00M | $-55.00M | $-1.51B | $2.32B | $552.00M | $1.50B | $-1.75B | $-1.13B | $-113.00M |
Cash at End of Period | $5.43B | $5.64B | $5.98B | $6.04B | $7.55B | $5.22B | $4.67B | $3.17B | $4.92B | $6.05B |
Cash at Beginning of Period | $5.64B | $5.98B | $6.04B | $7.55B | $5.22B | $4.67B | $3.17B | $4.92B | $6.05B | $6.16B |
Operating Cash Flow | $11.86B | $10.35B | $9.81B | $5.96B | $4.80B | $2.97B | $2.62B | $3.58B | $4.14B | $3.32B |
Capital Expenditure | $-4.59B | $-3.78B | $-2.57B | $-2.20B | $-2.61B | $-2.46B | $-1.37B | $-1.62B | $-2.31B | $-2.79B |
Free Cash Flow | $7.28B | $6.57B | $7.24B | $3.76B | $2.19B | $509.00M | $1.25B | $1.96B | $1.83B | $536.00M |